Modern patients are taking control of their own healthcare, from sharing information with one another to approaching industry organisations with their concerns. Tarquin Scadding-Hunt at …

A revolution is happening in the healthcare industry. Societal pressure to improve our health, technological advances, and market forces are all driving forward a novel …

Integration and increased automation are transforming the way life sciences companies manage much of their operational and regulatory information. Labelling and packaging content – so …

The pharmaceutical industry’s ongoing demand to shorten drug development times, thus making significant cost savings, is driving technological advances forward at the same time as …

The clinical development path is rife with complexity that can stall or stop a drug’s journey to market. Paul Evans, Jeetendra Rao and Abigaile Betteridge …

The current concept of clinical trial conduct is a balance between benefits from treatment (efficacy) and risks that this treatment may have (risk). Maxim Kosov, …

Primary bone sarcomas are cancers of mesenchymal, non-epithelial derivation, originating from bone cells or their precursors. Kelechi K. Olu MD, MSc, Vijayanand Rajendran and Mohamed …

The biopharmaceutical industry invests billions of dollars annually into clinical research to address a range of debilitating respiratory conditions. Phil Lake at ERT discusses how …

There are currently a number of pharmaceutical or device-based heart failure therapies in clinical use, with numerous promising candidates under development. Bobby Stutz and Dr …

Facioscapulohumeral MD, likely the most prevalent form of MD, currently has no cure, but several factors point to the potential for successful development of a …